JOLT Stock Overview
Jolt Health Inc. focuses on mental health and sexual wellness by licensing and distributing psychedelic and hemp–infused products in North America, the United Kingdom, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Jolt Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.025 |
| 52 Week Low | CA$0.005 |
| Beta | 1.56 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -66.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| JOLT | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | 26.2% | -1.1% |
| 1Y | -66.7% | 84.7% | 4.9% |
Return vs Industry: JOLT underperformed the Canadian Pharmaceuticals industry which returned 84.7% over the past year.
Return vs Market: JOLT underperformed the Canadian Market which returned 4.9% over the past year.
Price Volatility
| JOLT volatility | |
|---|---|
| JOLT Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 15.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: JOLT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine JOLT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Gerald Tritt | jolt-health.com |
Jolt Health Inc. focuses on mental health and sexual wellness by licensing and distributing psychedelic and hemp–infused products in North America, the United Kingdom, and Europe. It offers BLOOM, a topical clitoral stimulation gel; and AURALIEF, a hemp-infused sublingual strip. The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023.
Jolt Health Inc. Fundamentals Summary
| JOLT fundamental statistics | |
|---|---|
| Market cap | CA$636.45k |
| Earnings (TTM) | -CA$2.63m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs JOLT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JOLT income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.63m |
| Earnings | -CA$2.63m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.021 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did JOLT perform over the long term?
See historical performance and comparison